SEQUENCE, SHAPE, AND SPECIFICITY OF ANTIBODIES
SEQUENCE, SHAPE, AND SPECIFICITY OF ANTIBODIES
批准号:
3166432
负责人:
MICHAEL N MARGOLIES
金额:
$26.12万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-01 至 1991-06-30
关键词:
affinity chromatography antibody formation antibody specificity autoradiography biochemical evolution clone cells gel electrophoresis genetic mapping high performance liquid chromatography hybridomas immunochemistry immunoglobulin idiotypes laboratory mouse laboratory rabbit protein sequence radioimmunoassay site directed mutagenesis thin layer chromatography
中文摘要
在某些近亲繁殖的小鼠中,免疫反应主要由
英文摘要
In certain strains of inbred mice immune responses are dominated by
antibodies that share common variable region structures (idiotypes)
detected serologically by anti-idiotypic reagents. Idiotypic determinants
characterizing certain antibody specificities have proven valuable
structural and genetic markers in studies of antibody diversity and
regulation. Jerne proposed that interactions between idiotype and
anti-idiotype regulate immune responses through recognition of idiotypic
determinants, rather than by regulation of specific antigen combining
sites. The major cross-reacting idiotype (IdCR) in strain A/J mice
immunized with p-azophenylarsonate (Ars) is heritable and encoded by
germline genes. The Ars system is a model for examining regulations
defining the structural epitopes responsible for idiotypy and antibody
structure changes involved in enhanced antigen affinity occurring
temporally during the immune response (affinity maturation). A second
idiotype family (Id36-60) among anti-Ars antibodies shared in A/J and
BALB/c strains is serologically and structurally distinct from IdCR,
representing an independent marker for studies of regulation. The germline
VH genes for both IdCR and Id36-60 were cloned and sequenced. By
appropriate selection methods, the feasibility of isolating molecules in
which idiotype and antigen binding are dissociated, as well as obtaining
variants with enhanced affinity was demonstrated. Further the
3-dimensional structure of an IdCR Fab fragment is at hand. Therefore, we
will 1) Define the molecular site of IdCR by determining V region
structures of anti-Ars molecules which lack idiotype despite use of IdCR
associated gene segments, 2) Characterize the site and temporal pattern of
somatic mutation and its contribution to affinity changes among IdCR+ HP,
utilizing a) IdCR+ Ars-binding HP obtained during primary and secondary
immune responses, b) Spontaneous mutants in cell culture which do not bind
Ars or demonstrate enhanced binding. 3) Characterize the pattern of
structural changes seen during affinity maturation among Id36-60 antibodies
to assess the role of antigen driven selection in explaining why IdCR
dominates Id36-60, 4) Examine the contribution of gene junctional diversity
to Ars-binding by selecting of unmutated primary response antibodies with
junctional changes. 5) These studies are correlated with alterations in
idiotype and Ars-binding induced by site-directed mutagenesis and with
x-ray crystallographic analysis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ENGINEERING OF ANTIDIGOXIN ANTIBODY COMBINING SITES
-
批准号:2223643
-
项目类别:
-
资助金额:$30.83万
-
财政年份:1992
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
ENGINEERING OF ANTIDIGOXIN ANTIBODY COMBINING SITES
-
批准号:2750364
-
项目类别:
-
资助金额:$33.35万
-
财政年份:1992
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
ENGINEERING OF ANTIDIGOXIN ANTIBODY COMBINING SITES
-
批准号:2223641
-
项目类别:
-
资助金额:$26.98万
-
财政年份:1992
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
ENGINEERING OF ANTIDIGOXIN ANTIBODY COMBINING SITES
-
批准号:3366615
-
项目类别:
-
资助金额:$25.67万
-
财政年份:1992
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
ENGINEERING OF ANTIDIGOXIN ANTIBODY COMBINING SITES
-
批准号:6043778
-
项目类别:
-
资助金额:$34.68万
-
财政年份:1992
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
ENGINEERING OF ANTIDIGOXIN ANTIBODY COMBINING SITES
-
批准号:2459978
-
项目类别:
-
资助金额:$32.07万
-
财政年份:1992
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
ENGINEERING OF ANTIDIGOXIN ANTIBODY COMBINING SITES
-
批准号:3366616
-
项目类别:
-
资助金额:$26.07万
-
财政年份:1992
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
ENGINEERING OF ANTIDIGOXIN ANTIBODY COMBINING SITES
-
批准号:2223642
-
项目类别:
-
资助金额:$28.06万
-
财政年份:1992
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
SEQUENCE SHAPE AND SPECIFICITY OF ANTIBODIES
-
批准号:2087248
-
项目类别:
-
资助金额:$30.43万
-
财政年份:1986
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
SEQUENCE, SHAPE AND SPECIFICITY OF ANTIBODIES
-
批准号:2894503
-
项目类别:
-
资助金额:$37.75万
-
财政年份:1986
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
SEQUENCE SHAPE AND SPECIFICITY OF ANTIBODIES
-
批准号:2087249
-
项目类别:
-
资助金额:$0.6万
-
财政年份:1986
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
SEQUENCE, SHAPE AND SPECIFICITY OF ANTIBODIES
-
批准号:3166425
-
项目类别:
-
资助金额:$18.28万
-
财政年份:1986
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
SEQUENCE SHAPE AND SPECIFICITY OF ANTIBODIES
-
批准号:3166427
-
项目类别:
-
资助金额:$0.31万
-
财政年份:1986
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
SEQUENCE, SHAPE AND SPECIFICITY OF ANTIBODIES
-
批准号:3166430
-
项目类别:
-
资助金额:$18.74万
-
财政年份:1986
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
SEQUENCE SHAPE AND SPECIFICITY OF ANTIBODIES
-
批准号:2087250
-
项目类别:
-
资助金额:$31.97万
-
财政年份:1986
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
SEQUENCE, SHAPE AND SPECIFICITY OF ANTIBODIES
-
批准号:2767098
-
项目类别:
-
资助金额:$7.58万
-
财政年份:1986
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
SEQUENCE, SHAPE AND SPECIFICITY OF ANTIBODIES
-
批准号:3166429
-
项目类别:
-
资助金额:$20.17万
-
财政年份:1986
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
SEQUENCE, SHAPE, AND SPECIFICITY OF ANTIBODIES
-
批准号:3166433
-
项目类别:
-
资助金额:$30.57万
-
财政年份:1986
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
SEQUENCE, SHAPE AND SPECIFICITY OF ANTIBODIES
-
批准号:2414088
-
项目类别:
-
资助金额:$37.84万
-
财政年份:1986
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
SEQUENCE SHAPE AND SPECIFICITY OF ANTIBODIES
-
批准号:3166434
-
项目类别:
-
资助金额:$30.91万
-
财政年份:1986
-
负责人:MICHAEL N MARGOLIES
-
依托单位:
海外基金